Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India Study

BACKGROUND AND AIMS: It is not known if new onset diabetes during Coronavirus-19 disease (COVID-19; NOD COVID) is phenotypically or biochemically different than new onset diabetes before COVID-19 (NOD). METHODS: All adults diagnosed with new onset diabetes from during the time of COVID-19 were compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Amerta, Anjana, Ranjit Mohan, Shanthi Rani, Coimbatore Subramanian, Jeba Rani, Saravanan, Gupta, Ritesh, Jha, Alka, Gupta, Vimal, Kuchay, Mohammad Shafi, Luthra, Atul, Durrani, Suhail, Dutta, Koel, Tyagi, Kanika, Unnikrishnan, Ranjit, Srivastava, Brijendra Kumar, Ramu, Muthu, Sastry, Nadiminty Ganapathi, Gupta, Prasanna Kumar, Umasankari, Ganesan, Jayashri, Ramamoorthy, Mohan, Viswanathan, Misra, Anoop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771314/
https://www.ncbi.nlm.nih.gov/pubmed/33450530
http://dx.doi.org/10.1016/j.dsx.2020.12.033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771314/
https://www.ncbi.nlm.nih.gov/pubmed/33450530
http://dx.doi.org/10.1016/j.dsx.2020.12.033

Ejemplares similares